COMMUNIQUÉS West-GlobeNewswire

-
Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference
12/05/2025 -
Akoya Biosciences Reports First Quarter 2025 Financial Results
12/05/2025 -
Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
12/05/2025 -
Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/05/2025 -
Mineralys Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
12/05/2025 -
Jasper Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
12/05/2025 -
FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update
12/05/2025 -
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
12/05/2025 -
Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors
12/05/2025 -
Stereotaxis Reports 2025 First Quarter Financial Results
12/05/2025 -
Relmada Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
12/05/2025 -
Xenon Reports First Quarter 2025 Financial Results and Provides Business Update
12/05/2025 -
Syndax Pharmaceuticals Appoints Dr. Nicholas Botwood as Head of Research and Development and Chief Medical Officer
12/05/2025 -
Editas Medicine Announces U.S. Court of Appeals for the Federal Circuit Remands CRISPR Patent Interference to Patent Trial and Appeal Board
12/05/2025 -
Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
12/05/2025 -
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
12/05/2025 -
IBA – ACQUISITION OF OWN SHARES
12/05/2025 -
IBA – ACQUISITION D’ACTIONS PROPRES
12/05/2025 -
Fagron shareholders approve all voting items AGM
12/05/2025
Pages